ÐÂÎÅ×ÊѶ
ϲ±¨ | J9¼¯ÍÅÔìÒ©¼¯ÍÅWP107£¨Ê¯É¼¼î¼×¿Ú·þÈÜÒº£©ÁÙ´²ÊÔÑéÉêÇë»ñÖйúCDEÊÜÀí
ÈÕÆÚ£º
2026Äê04ÔÂ01ÈÕ 15:16
Öйú±±¾©¹¦·ò2025Äê04ÔÂ24ÈÕ£¬Öйú¹ú¶ÈÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©£¬ÕýʽÊÜÀíÁ˱¾¹«Ë¾×ÔÖ÷Ñз¢µÄʯɼ¼î¼×ÐÂÐͿڷþÔì¼Á“ʯɼ¼î¼×¿Ú·þÈÜÒº”£¨Ñз¢²úÆ·´úºÅWP107£©Ò½ÖÎÈ«ÉíÐͳÁÖ¢¼¡ÎÞÁ¦µÄÐÂÒ©ÁÙ´²ÊÔÑ飨IND£©ÉêÇ룬ÊÜÀíºÅCXHL2500409¡£¸ÃÊÜÀí±ê־ȡWP107ÐÂÒ©ÔÚÖйúµÄÑз¢Í¬²½½øÈëÁÙ´²½×¶Î¡£
WP107Ϊʯɼ¼î¼×ÐÂÐͿڷþÈÜÒº¼ÁÐÍ£¬×¨Îª¿ÉÄÜ´æÔÚÍÌÑÊÄÑÌâµÄ³ÁÖ¢¼¡ÎÞÁ¦»¼Õß¼°¶ùͯ»¼ÕßÉè¼Æ¡£Ê¯É¼¼î¼××÷ΪһÖָ߻îÐÔ¡¢¸ßÑ¡ÔñÐԵĵ¨¼îõ¥Ã¸ÒÖÔì¼Á£¬Í¬Ê±ÓµÓÐÃâÒßµ÷½Ú¡¢¿¹Ñõ»¯Ó¦¼¤µÈ×÷Óã¬ÇÒ¿Ú·þÉúÎïÀûÓöÈÓÅÁ¼¡£ÁÙ´²×êÑÐÅú×¢£¬Ê¯É¼¼î¼××¢ÉäÒºÔÚÒ½ÖγÁÖ¢¼¡ÎÞÁ¦·½ÃæÓµÓа²È«ÐԺᢼ±¾çÆðЧ¡¢×÷ÓÃÏÔÖøÇÒ³ÖÐø¹¦·òÓÆ¾ÃµÄÓÅÊÆ¡£
Õâ´ÎCDEÊÜÀíµÄÁÙ´²ÊÔÑéΪο½å¼Á¶ÔÕÕÊÔÑ飬ּÔÚÆÀ¹ÀWP107ÔÚÈ«ÉíÐͳÁÖ¢¼¡ÎÞÁ¦»¼ÕßÖеݲȫÐÔ¡¢Ò©´ú¶¯Á¦Ñ§ºÍÁÙ´²ÓÐЧÐÔ¡£¹«Ë¾ÓÚ2023Äê12Ô»ñµÃFDAÊÚÓèµÄʯɼ¼î¼×Ò½ÖγÁÖ¢¼¡ÎÞÁ¦µÄ¹Â¶ùÒ©È϶¨£¨orphan drug designation£¬ODD£©£¬²¢ÓÚÃÀ¹ú¶«²¿¹¦·ò2025Äê01ÔÂ14ÈÕ»ñµÃÃÀ¹úFDAÊÚÓèµÄÐÂÒ©ÁÙ´²ÊÔÑé·¢Õ¹Ðí¿É£¬ÔÚÑз¢¡¢×¢²á¼°Ã³Ò×»¯µÈ·½ÃæÏíÊܶàÏîÃÀ¹úµÄÕþ²ßÖ§³Ö£¬Ô̺¬ÁÙ´²ÊÔÑéÓöȵÄ˰ÊÕµÖÃâ¡¢ÃâÈ¥ÐÂÒ©ÉêÇë·Ñ¡¢¼Ó¿ìÉóÆÀÉóÅú×ʸñµÈ£¬²úÆ·»ñÅúºó½«ÏíÊÜ7ÄêµÄÊг¡¶ÀռȨ£¬½«À´Ò²½«»ñµÃ¸ü¶àCDEµÄÕþ²ßÁìµ¼¡£
J9¼¯ÍÅÔìÒ©½«³ÖÐøÍÆ¶¯¸ÃÑз¢ÏîÄ¿£¬»ý¼«×öºÃ¸ÃÏîÄ¿ÁÙ´²×êÑеijﱸÓë·¢Õ¹£¬Á¦ÇóʵÏÖWP107ÔÚÖÐÃÀÁ½¹úµÄÔçÈÕÉÏÊУ¬²¢½«ÕâÒ»ÓÃÒ©¾Þ´óDZÔÚÁÙ´²ÓÅÊÆµÄÁÆ·¨´ø¸øÈ«Çò³ÁÖ¢¼¡ÎÞÁ¦»¼Õß¡£
¹ØÓÚʯɼ¼î¼×
ʯɼ¼î¼×ÖØÒª×÷ÓûúÀíΪÒÒõ£µ¨¼îõ¥Ã¸ÒÖÔ죬ͬʱӵÓп¹Ñס¢¿¹Ñõ»¯Ó¦¼¤ÓëÉñ¾±£»¤µÈ×÷Óá£ÒòÆäÁÆÐ§ÏÔÖø¡¢ÆðЧѸ¿ì¡¢×÷Óù¦·ò½Ï³¤£¬ÒÔ¼°°²È«ÐÔÓÅÁ¼£¬ÓÐÍûΪ³ÁÖ¢¼¡ÎÞÁ¦»¼Õß´øÀ´¸üÓŵÄÁÙ´²Ñ¡Ôñ¡£
J9¼¯ÍÅÔìÒ©¼¯ÍÅÕ¼ÓÐʯɼ¼î¼×ÔÁÏÒ©µÄºË×¼Îĺţ¬ÊǹúÄÚÖØÒªµÄʯɼ¼î¼×ÔÁÏÒ©¹©¸øÉÌ¡£¹«Ë¾¹úÄÚʯɼ¼î¼××¢ÉäÒºÒѾÉÏÊУ¬²¢ÓÐʯɼ¼î¼×¿ØÊÍÆ¬ÔÚ·¢Õ¹Ò½Öΰ¢¶û´Äº£Ä¬Ö¢µÄÁÙ´²×êÑС£
Õâ´ÎIND»ñµÃÖйúCDEÊÜÀí£¬Êǹ«Ë¾»ý¼«Íƶ¯WP107ÖÐÃÀË«±¨Ñз¢½ø¶È¡¢½«ÕâÒ»ÖйúÔ´´ÐÂҩͬ²½Ô츣ÖйúÈËÃñµÄÓÖÒ»³É¾Í£¬³ÉΪ¹«Ë¾Õë¶Ôʯɼ¼î¼×µÄмÁÐÍ¡¢ÐÂÊÊÓ¦Ö¢¡¢ÐÂÊг¡µÈ´´ÐÂÐÔ²¼¾ÖµÄ³ÁÒª×é³É²¿ÃÅ¡£
¹ØÓÚ³ÁÖ¢¼¡ÎÞÁ¦
³ÁÖ¢¼¡ÎÞÁ¦£¨MG£©ÊÇÒ»ÖÖº±¼ûµÄÂýÐÔ×ÔÉíÃâÒßÐÔÉñ¾¼¡Èâ¼²²¡£¬¿ÉÄܵ¼ÖÂÒò¼¡ÈâÎÞÁ¦¶øÖ²У¬ÉõÖÁÒòºôÎüË¥½ß¶øéæÃü¡£³ÁÖ¢¼¡ÎÞÁ¦µÄÁÙ´²ÑϳÁˮƽ¿É´ÓÇá΢µÄÑÛ²¿Ö¢×´£¨ÀýÈçÑÛíúÏ´¹¡¢¸´ÊÓ£©µ½ºôÎüºÍÑÓËèΣÏó£¬Î£¼°ÐÔÃü£¬±ØÒª³ÁÖ¢¼à»¤¡¢Í¨ÆøÖ§³ÖºÍ³¦ÄÚÎ¹Ñø¡£ÆäËûÖ¢×´¿ÉÄÜÔ̺¬ÒòÃæ²¿¼¡ÈâÎÞÁ¦¶øÎÞ·¨½øÐÐÃæ²¿±íÇé¡¢ÍÌÑÊ»ò´ë´ÇÄÑÌ⣬ÒÔ¼°Éí¶ÎÆäËû²¿Î»£¨Èç¾±²¿¡¢ÉÏÖ«ºÍÏÂÖ«£©¼¡ÈâÎÞÁ¦¡£Ô¼Äª20%µÄ»¼ÕßÖ»»á³öÏÖÑÛ²¿ÎÞÁ¦£¨³ÆÎªÑÛ¼¡ÐÍMG£©£¬¶øÆäËûÈ«ÉíÐÔ³ÁÖ¢¼¡ÎÞÁ¦£¨gMG£©»¼ÕßÒ²»á³öÏÖÉí¶ÎÆäËû²¿Î»µÄÎÞÁ¦¡£ÔÚÈ«ÇòÁìÓòÄÚ£¬MG »¼²¡ÂʹÀ¼ÆÎªÃ¿ 10 ÍòÈËÖÐÓÐ12.4Àý¡£Æ¾¾Ý2022ÄêÖйú³ÁÖ¢¼¡ÎÞÁ¦»¼Õß½¡È«»ã±¨£¬ÔÚÎÒ¹ú£¬MGµÄ·¢²¡ÂÊԼΪ7.4Àý/°ÙÍòÈË/Ä꣬ÊôÓÚº±¼û²¡¡£[1] È»¶ø£¬ÓÉÓÚMGÈÔδµÃµ½³ä·ÖÕï¶Ï£¬ÏÖʵÊÀ½çÖеϼ²¡ÂÊ¿ÉÄÜÒÀÈ»½Ï¸ß¡£
±¾¹«Ë¾µÄʯɼ¼î¼×¿Ú·þÈÜÒº£¬ÓÐÍûΪ»¼ÕßÌṩÁÆÐ§ÏÔÖø¡¢°²È«ÐÔ¸üºÃµÄÒ½ÖÎÑ¡Ôñ¡£ÊÀ½çÁìÓòÄÚ£¬È«Çò³ÁÖ¢¼¡ÎÞÁ¦Ò½ÖÎÊг¡Ô¤¼Æµ½2032Ä꽫´ïµ½67ÒÚÃÀÔªÒÔÉÏ[2]£¬ÆäÖйúÄÚÊг¡ÊdzÁÖ¢¼¡ÎÞÁ¦µÄ¹Ø¼üÊг¡Ö®Ò»¡£
¹ØÓÚJ9¼¯ÍÅ
J9¼¯ÍÅÔìÒ©¼¯ÍÅʼ´´ÓÚ1970Ä꣬×ܲ¿Î»ÓÚÕã½Ê¡Ì¨ÖÝÎÂÁëÊУ¬ÊÇרҵ´ÓÊÂÏÖ´úÖÐÒ©¡¢»¯Ñ§ÔÁÏÒ©¼°Ôì¼ÁÑз¢¡¢³ö²úºÍÏúÊ۵ĸßм¼ÊõÆóÒµ£¬×¢²á±¾Ç®Îª3.6ÒÚÔª£¬ÏÖÕ¼ÓÐ6¼Ò×Ó¹«Ë¾£¬Ò©Æ·³ö²úºË×¼ÎĺÅ185¸ö£¬Éæ¼°14¸ö¼ÁÐÍ¡£¹«Ë¾³ÖÐø»ñµÃ"ÖйúÒ½Ò©ÐÐÒµ³É³¤50Ç¿ÆóÒµ","ÖлªÃñ×åÒ½Ò©°ÙÇ¿Æ·ÅÆÆóÒµ","ÖйúÒ½Ò©¹¤Òµ×î¾ß³É³¤Á¦ÆóÒµ","ÖгÉÒ©ÆóÒµ100Ç¿"¡£¹«Ë¾×¢²áÉ̱걻È϶¨ÎªÖйú³ÛÃûÉ̱ꡣ
×ñÑ"ÃæÏò»¼Õß¡¢ÃæÏòÊÀ½ç¡¢ÃæÏò½«À´"µÄÒ©Æ·Ñз¢ÀíÏ룬¹«Ë¾²»½öÖÂÁ¦ÓÚ¼ÓÇ¿·ÂÔìÒ©Ôì¼ÁÓëÔÁÏÒ©µÄ²î¾à»¯¿ª·¢µÄÊг¡¾ºÕùÁ¦£¬Í¬Ê±Ò²´òËã²¼¾Ö1ÀàÐÂÒ©£¨Ð»¯Ñ§ÊµÌ壩ºÍÒÀ¸½505( b )(2£©õè¾¶µÄ2ÀàÐÂÒ©¿ª·¢¡£´Ë±í£¬J9¼¯ÍÅÔìÒ©¼¯ÍÅ»¹ÖÂÁ¦ÓÚͨ¹ý²¼¾ÖÈ«ÇòºÏ×÷¼Ó¿ìÒ©Æ·µÄÑз¢¹ý³Ì£¬Æô·¢º£±íÊг¡»Ý¼°¸ü¿í·ºµÄ»¼ÕßȺÌå¡£ÕâÒ»Õ½ÊõÖ¼ÔÚΪ»¼ÕßÌṩ¸ü°²È«¡¢¸üÓÐЧµÄÁÙ´²Ò½ÖÎÑ¡ÏÒÔÂú×ãÈÕÒæÔö³¤µÄÁÙ´²ÐèÒª¡£

[1]ÖйúºìÊ®×Ö»ù½ð»á. Öйú³ÁÖ¢¼¡ÎÞÁ¦»¼Õß½¡È«»ã±¨2022[R]. 2022..
[2]Clinical Trials Arena, Myasthenia gravis market to generate sales of $6.7bn by 2032, November 17, 2023. URL: https://www.clinicaltrialsarena.com/analyst-comment/myasthenia-gravis-market-to-generate-sales-of-6-7bn-by-2032/
ÓйØÍƼö